Award notice Supplies
Fourniture de sugammadex
Notice published in French. The AI analysis summarises it for you in your language.
- Public buyer
- MercurHosp ASBL
Erpent - Place of performance
- 5101 Erpent, Namur
not published: buyer's address - Planned end of contract
- 15 December 2027
likely re-tender around June 2027 - Bids received
- 2
- Procedure
- Open procedure
Any company may submit a bid. - Publication
- 29 January 2024
- Notice language
- French
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Marché de fourniture de sugammadex (agent décurarisant utilisé pour l'antagonisation des effets myorelaxants du rocuronium et du vécuronium au cours de l'anesthésie générale ) en dosage de 200 mg/2ml et 500 mg/5ml en flacon.
Awarded to
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €269,390
- Median
- €449,863
- A quarter above
- €962,736
Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Fourniture d'azaticidine MercurHosp ASBL · 3 August 2026 |
Fresenius Kabi | €67,433 |
| Générateurs de Technétium (99M Tc) et produits radiopharmaceutiques MercurHosp ASBL · 1 October 2025 |
GE HEALTHCARE CISBIO International Curium Belgium |
€12,256,476 |
| Fourniture d'analogues de la somatostatine MercurHosp ASBL · 1 October 2025 |
Pharmanovia Benelux B.V. NOVARTIS PHARMA |
€606,086 |
| Fourniture de Gemcitabine MercurHosp ASBL · 30 September 2025 |
ACCORD HEALTHCARE | €256,160 |
| ATOSIBAN IV MercurHosp ASBL · 30 September 2025 |
FERRING | €391,336 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 56983-2024.